- 31/01/2022
-
Russia’s Electrochemical Plant sees record revenue from isotopes
In 2021, the revenue from the sale of isotope products from Russia's Electrochemical Plant (part of Rosatom's Fuel Company TVEL) increased by 8% year-on-year, to more than RUB1.6 billion ($20m) for the first time.
- 26/01/2022
-
100+ international companies and organisations partake in ROSATOM’s “Breakthrough Technologies for a Sustainable Future” week at EXPO-2020
Taking place as part of World Expo 2020 in Dubai (UAE), ROSATOM’s thematic weeklong event “Breakthrough Technologies for a Sustainable Future” came to a close on January 24. The event – unprecedented in terms of scale – saw ROSATOM representatives taking part in 18 sessions dedicated to the role of advanced technologies in achieving a sustainable future and solving the most pressing challenges of our time.
- 19/01/2022
-
Rusatom Healthcare JSC at the Dubai EXPO
Rusatom Healthcare JSC is part of the Russian pavilion at the Dubai EXPO where they organised a discussion on “non energy applications of nuclear technology for addressing global challenges”.
- 09/11/2021
-
ROSATOM takes part in “Clean Nuclear Energy Day” events at COP26
8 November 2021, Glasgow, UK – “Clean Nuclear Energy Day” took place on November 8 as part of the twenty-sixth session of the Conference of the Parties (COP26), held in the United Nations Framework Convention on Climate Change (UNFCCC). The special “Clean Nuclear Energy Day” programme was made possible with ROSATOM’s support.
- 24/10/2021
-
Isotope JSC - partner of the EANM Congress 2021
Isotope JSC participated in 34th Annual Congress of the European Association of Nuclear Medicine on October 20-23, 2021. Due to the pandemic, the congress was held virtually for the second year in a row.
- 04/10/2021
-
ROSATOM’s Sustainable Development Report posted on the website of the UN Global Compact Network for the first time
The ROSATOM’s first Sustainable Development Report for 2020 was first posted on the website of the UN Global Compact Network October 1, 2021. The report is qualified rated at level “Active”.
- 09/09/2021
-
Isotope JSC took part in the Brazilian Congress of Nuclear Medicine 2021
ROSATOM took part in the XXXV Brazilian Congress of Nuclear Medicine (CBMN) as a Gold Sponsor. The event took place in Brazil on September, 3-6. Due to the coronavirus pandemic, the event was held virtually.
- 06/09/2021
-
Isotope JSC experts participated in the oncological conference in Italy
On September, 2-4 representatives of Isotope JSC took part in the second Russian-Italian scientific conference "Challenges of oncology in the era of COVID-19 ", held in a hybrid format in Taranto (Italy).
- 30/07/2021
-
Isotope JSC took part in the international Nuclear Trade and Technology Exchange (NT2E) conference
ROSATOM took part in the international online conference Nuclear Trade and Technology Exchange (NT2E), organized by the Brazilian Association for the Development of Nuclear Activities (ABDAN) on July 27-29, 2021.
- 09/06/2021
-
ROSATOM to supply Brazil with promising isotopes needed in Nuclear Medicine
Isotope JSC (a part of Rusatom Healthcare JSC, Rosatom’s radiation technologies integrator) has signed a five-year contract with Brazil’s Nuclear and Energy Research Institute (IPEN; linked to the National Nuclear Energy Commission or CNEN) to supply lutetium-177 and actinium-225, the most promising medical isotopes in Radiopharma.